Bayesian Capital Management, LP Coherus Bio Sciences, Inc. Transaction History

Bayesian Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$2.02 - $3.14 $47,589 - $73,975	23,559 New	23,559 $56,000
Q4 2022 Feb 14, 2023	BUY	$5.69 - $10.07 $135,422 - $239,666	23,800 New	23,800 $188,000
Q1 2020 May 15, 2020	SELL	$11.67 - $22.53 $122,955 - $237,376	-10,536 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.33 - $21.37 $172,052 - $225,154	10,536 New	10,536 $190,000
Q2 2018 Aug 14, 2018	SELL	$10.25 - $17.45 $200,900 - $342,020	-19,600 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.1 - $13.7 $178,360 - $268,520	19,600 New	19,600 $217,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.